Stone JM, Davis JM, Leucht S, Pilowsky LS. Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Schizophrenia bulletin. 2009;35(4):789-97.

Leucht S, Huhn M, Davis JM. Should 'typical', first-generation antipsychotics no longer be generally used in the treatment of schizophrenia? European archives of psychiatry and clinical neuroscience. 2021;271(8):1411-3.

Panizzutti B, Bortolasci CC, Spolding B, Kidnapillai S, Connor T, Martin SD, et al. Effects of antipsychotic drugs on energy metabolism. European archives of psychiatry and clinical neuroscience. 2023.

Seeman P. Atypical antipsychotics: mechanism of action. Canadian journal of psychiatry Revue canadienne de psychiatrie. 2002;47(1):27-38.

Oh S, Byeon SJ, Chung SJ. Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019. J Psychopharmacol. 2022;36(9):1041-50.

Yin S. Psychopharmacologic Agents. In: Cydulka RK, Fitch MT, Joing SA, Wang VJ, Cline DM, Ma OJ, editors. Tintinalli's Emergency Medicine Manual, 8e. New York, NY: McGraw-Hill Education; 2017.

Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 Suppl 3):S829-61.

Walls RM, Hockberger RS, Gausche-Hill M, Erickson TB, Wilcox SR. Rosen's Emergency Medicine: Concepts and Clinical Practice: Elsevier; 2022.

Divac N, Prostran M, Jakovcevski I, Cerovac N. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014;2014:656370.

N. Juurlink D. Antipsychotics. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank's Toxicologic Emergencies, 11e. New York, NY: McGraw-Hill Education; 2019.

Anderson M. Poisoning in young children. Archives of disease in childhood. 2012;97(9):831-2.

French R, Brooks D, Ruha AM, Shirazi F, Chase P, Boesen K, et al. Gila monster (Heloderma suspectum) envenomation: Descriptive analysis of calls to United States Poison Centers with focus on Arizona cases. Clinical toxicology (Philadelphia, Pa). 2015;53(1):60-70.

Manouchehrifar M, Derakhshandeh N, Shojaee M, Sabzghabaei A, Farnaghi F. An Epidemiologic Study of Pediatric Poisoning; a Six-month Cross-sectional Study. Emergency (Tehran, Iran). 2016;4(1):21-4.

Schwebel DC, Evans WD, Hoeffler SE, Marlenga BL, Nguyen SP, Jovanov E, et al. Unintentional child poisoning risk: A review of causal factors and prevention studies. Children's Health Care. 2017;46(2):109-30.

Cobaugh DJ, Erdman AR, Booze LL, Scharman EJ, Christianson G, Manoguerra AS, et al. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management. Clinical toxicology (Philadelphia, Pa). 2007;45(8):918-42.

Epidemiology of poisoning in children admitted to Urmia Imam hospital, during 2002-2006. Iranian Journal of Forensic Medicine. 2009;15(3):171-5.

Farnaghi F, Hassanian-Moghaddam H, Faghihi Langroodi T. Fatal Poisoning and its Related Factors among Children Admitted in Loghman Hospital, 1995 -2004. Pajoohande. 2009;13(6):529-35.

Haresabadi M, Sedaghat M, Vejdani M, Ahrari S, Toghian CHaharsougi N, Momeni A. Epidemiologic Study of acute poisoning in children aged under 12 years referred to Imam Reza hospital, 2010-2012. North Khorasan University of Medical Sciences. 2013;5(1):47-52.

Jiang Y, McCombs JS, Park SH. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics. CNS Drugs. 2017;31(4):319-26.

Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341-56.

Meli M, Rauber-Lüthy C, Hoffmann-Walbeck P, Reinecke HJ, Prasa D, Stedtler U, et al. Atypical antipsychotic poisoning in young children: a multicentre analysis of poisons centres data. Eur J Pediatr. 2014;173(6):743-50.

Fakherinia E, Talebi P, Mahmodpoor G. Study on Etiology and incidence of chemical, drug and plant poisioning in 1-15 years patients referred to emergency wards in ardabil.

Isbister GK, Balit CR, Kilham HA. Antipsychotic poisoning in young children: a systematic review. Drug Saf. 2005;28(11):1029-44.

Stassinos G, Klein-Schwartz W. Comparison of pediatric atypical antipsychotic exposures reported to U.S. poison centers. Clinical Toxicology. 2017;55(1):40-5.

Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT. Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2004;14(3):372-94.

Fleischhaker C, Heiser P, Hennighausen K, Herpertz-Dahlmann B, Holtkamp K, Mehler-Wex C, et al. Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics. J Child Adolesc Psychopharmacol. 2006;16(3):308-16.

Tan HH, Hoppe J, Heard K. A systematic review of cardiovascular effects after atypical antipsychotic medication overdose. Am J Emerg Med. 2009;27(5):607-16.

Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, et al. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2016;26(10):900-8.